Shree Kumari Gr

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersFood properties (incl. characteristics and health benefits)Biologically active moleculesIndustrial microbiology (incl. biofeedstocks)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
p53 mediated cell cytotoxicity and DNA damage in lung cancer cell line A549 triggered by a small peptide extracted from a probiotic strain Lacticaseibacillus casei.

Jannatul Firdous Siddique, G R Shree Kumari, Sudarshana Deepa Vijay Kumar

|Jul 07, 2025
Scaling Up Postbiotics Production: A Prospective Review of Processes and Health Benefits.

Shree Kumari G R, Mohanasrinivasan V

|Sep 12, 2024
In silico analysis reveals α-amylase inhibitory potential of Taraxerol (<i>Coccinia indica</i>) and Epoxywithanolide-1 (<i>Withania coagulans</i>): a possible way to control postprandial hyperglycemia-induced endothelial dysfunction and cardiovascular events.

Lokesh Ravi, Venkatesh Sadhana, Pratishtha Jain

|Feb 14, 2024
Behenic Acid as a multi-target inhibiting antibacterial phytochemical against <i>Vibrio parahaemolyticus</i> and <i>Aeromonas hydrophila</i> for effective management of aquaculture infections: an in-silico, in-vitro & in-vivo experimentation.

Lokesh Ravi, Ajith Kumar K, Shree Kumari G R

|Sep 11, 2023
Stearyl palmitate a multi-target inhibitor against breast cancer: in-silico, in-vitro & in-vivo approach.

Lokesh Ravi, Ajith Kumar K, Shree Kumari G R

|Mar 07, 2023
β-Sitosterol, a phytocompound from <i>Parthenium hysterophorus,</i> reveals anti-diabetic properties through α-Amylase inhibition: an i<i>n-silico</i> and <i>in-vitro</i> analysis.

Lokesh Ravi, Shabari Girish, Sharun Roy D'Souza

Pageof 1

Frequent Collaborators

4 joint publications

Mohanasrinivasan Vaithilingam

4 joint publications

Lokesh Ravi

4 joint publications

Ajith Kumar Krishnan

2 joint publications

Reji Manjunathan